Figure 2
From: Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis
Forest plots assessing the effects of different P2Y12 inhibitors relative to clopidogrel. (A) Cardiovascular mortality. (B) Myocardial infarction. (C) Stroke. (D) MACE. (E) Definite or probable stent thrombosis. (F) All-cause mortality. MACE = major adverse cardiovascular events. Square markers indicate odds ratios for cardiovascular outcomes comparing different P2Y12 inhibitors to clopidogrel. The horizontal lines indicate 95% confidence intervals.
